Comparison of the pharmaceutical properties of sustained-release gel beadsprepared by alginate having different molecular size with commercial sustained-release tablet

Citation
T. Imai et al., Comparison of the pharmaceutical properties of sustained-release gel beadsprepared by alginate having different molecular size with commercial sustained-release tablet, PHARMAZIE, 55(3), 2000, pp. 218-222
Citations number
15
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMAZIE
ISSN journal
00317144 → ACNP
Volume
55
Issue
3
Year of publication
2000
Pages
218 - 222
Database
ISI
SICI code
0031-7144(200003)55:3<218:COTPPO>2.0.ZU;2-M
Abstract
Spherical alginate gel beads containing pindolol were prepared using three types of sodium alginate with different molecular size. The rate of gelatio n of sodium alginate in calcium chloride solution was in the range of 1.0 t o 1.3 h(-1) among the used three alginates, but the amount of water squeeze d from the alginate gel beads during gelation increased from 5 to 40% with increasing molecular size of the alginate. The beads prepared were similar in diameter (1.2 mm after drying), weight (0.9 mg/bead), calcium content (2 7-29 mu g/bead) and pindolol content (40-45%). Pindolol was rapidly release d from all the alginate gel beads at pH 1.2 owing to the high solubility of pindolol, in spite of non-swelling of beads. On the other hand, pindolol r elease from alginate gel beads at pH 6.8 was dependent on the swelling of t he beads and was significantly depressed compared to drug powder. Interesti ngly, the release rate of pindolol and the swelling rate of beads were mark edly slow for gel beads prepared by low molecular size alginate. However, w hen the alginate gel beads were administered orally to beagle dogs, the ser um levels of pindolol showed sustained-release profiles, depending on the m olecular size of the alginate. The in vivo absorption of pindolol from algi nate gel beads did not reflect their in vitro release profiles, because of a physical strength of beads in the intestinal tract. Furthermore, the in v ivo and in vitro release of pindolol from alginate gel beads were compared with a commercial sustained-release tablet, Carvisken(R) showed a rapid rel ease of 50% of content in pH 1.2 fluid and residual 50% of pindolol were ea sily dissolved at pH 6.8. Although the release characteristics of pindolol from Carvisken(R); and the alginate gel beads were completely different, th e serum levels of pindolol in human volunteers were comparable.